Mutation analysis of the TIA1 gene in Chinese patients with amyotrophic lateral sclerosis and frontotemporal dementia
Mutation analysis of the TIA1 gene in Chinese patients with amyotrophic lateral sclerosis and frontotemporal dementia
复制标题
DOI:
10.1016/j.neurobiolaging.2017.12.017
复制
发表时间:
2017-12
影响因子:
4.2
通讯作者:
Zhenhua Yuan;Bin Jiao;Li-li Hou;Tingting Xiao;Xi-xi Liu;Junling Wang;Jun Xu;Lin Zhou;Xinxiang Yan;B. Tang;Lu Shen
中科院分区:
文献类型:
--
作者:
Zhenhua Yuan;Bin Jiao;Li-li Hou;Tingting Xiao;Xi-xi Liu;Junling Wang;Jun Xu;Lin Zhou;Xinxiang Yan;B. Tang;Lu Shen
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of motor neurons in the brain and spinal cord. Frontotemporal dementia (FTD) is a group of dementia syndromes characterized by the progressive deterioration of behaviors, executive dysfunction, and verbal impairment. Increasing evidence indicates that these 2 diseases share a common genetic etiology and pathophysiological mechanism. Recently, rare mutations in the low-complexity domain of the RNA-binding protein T-cell–restricted intracellular antigen-1 (TIA1) gene were identified in Caucasian ALS and ALS-FTD patients. However, no comprehensive mutation analysis of theTIA1gene has been performed in Chinese patients with ALS and FTD. In this study, we screened the low-complexity domain ofTIA1in a cohort of 241 ALS and 51 FTD patients in mainland China. As a result, 2 novel missense mutations (p.P352L and p.I300T) were identified in 2 sporadic patients with ALS, while no mutation was found in FTD cases. To the best of our knowledge, this report presented the first mutation analysis of theTIA1gene in patients with ALS and FTD in Chinese population. Our findings broaden the known mutational spectrum in patients with ALS and further confirmTIA1as a novel causative gene of ALS.